Thomas Gidoin Joins OSE Immunotherapeutics as Chief Financial Officer
August 20, 2025 - 23:13
NANTES, France, August 20, 2025 – OSE Immunotherapeutics SA has officially announced the appointment of Thomas Gidoin as its new Chief Financial Officer. With over 15 years of extensive experience in capital markets and financial strategy, Gidoin brings a wealth of knowledge and expertise to the company’s Executive Committee.
Gidoin's background in biopharma finance is marked by a strong track record in strategic financial leadership, which he has demonstrated in both private and public sectors. His appointment is anticipated to enhance OSE Immunotherapeutics' financial governance and strategic initiatives, positioning the company for future growth and success.
The addition of Gidoin to the leadership team is seen as a pivotal move to strengthen the company's financial operations and align its strategies with the evolving landscape of the biopharmaceutical industry. Stakeholders and investors alike are looking forward to the insights and direction he will bring in his new role.
MORE NEWS
May 26, 2026 - 06:29
Asian Currencies Consolidate as Traders Assess Mideast DevelopmentsAsian currencies traded in a narrow range against the U.S. dollar on Tuesday, as investors paused to assess the latest geopolitical developments in the Middle East. The region`s foreign exchange...
May 25, 2026 - 08:09
Semtech (SMTC) Q1 Earnings: What To ExpectSemiconductor company Semtech is scheduled to release its first-quarter earnings after the market closes on Tuesday. Investors are watching closely for updates on the company`s turnaround efforts...
May 24, 2026 - 23:08
The 2022 Bitcoin Pattern Is Back — and the Second Drop Was Worse Than the FirstA familiar and troubling chart pattern from 2022 has resurfaced in Bitcoin`s price action, and the latest leg down has been even more severe than the initial decline. Ran Neuner recently appeared...
May 24, 2026 - 02:33
4.4 Months of Housing Supply: Why That’s Still Leaving Buyers BehindThe number of homes for sale finally grew in April, but the shift is too small to give buyers much relief. The National Association of REALTORS reported that unsold inventory rose 5.8% from March,...